Expression of PIP4K2A in Lymphocyte Cell Lines from a sample of schizophrenia patients with previous evidence for association

Schizophrenia Research

Volumn 130, Issue 1-3, 2011, Pages 295-296

  Saggers Gray, Llewellyn ^a,b   Wildenauer, Dieter B ^b,c   Schwab, Sibylle G ^a,b,d,e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c GRAYLANDS HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GAPDH GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GUSB GENE; HUMAN; HUMAN CELL; LETTER; LYMPHOID CELL LINE; MALE; PIP4K2A GENE; PRIORITY JOURNAL; SCHIZOPHRENIA;

FEMALE; GENE EXPRESSION; HUMANS; LYMPHOCYTES; MALE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RANDOM ALLOCATION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 79960332445     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.02.010     Document Type: Letter

References (10)

1. Bakker S.C., Hoogendoorn M.L., Hendriks J., Verzijlbergen K., Caron S., Verduijn W., Selten J.P., Pearson P.L., Kahn R.S., Sinke R.J. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav. 2007, 6(2):113-119.
2. Brown D.A., Hughes S.A., Marsh S.J., Tinker A. Regulation of M(Kv7.2/7.3) channels in neurons by PIP(2) and products of PIP(2) hydrolysis: significance for receptor-mediated inhibition. J. Physiol. 2007, 582(3):917-925.
3. Conn P.J., Sanders-Bush E. Biochemical characterization of serotonin stimulated phosphoinositide turnover. Life Sci. 1986, 38(7):663-669.
4. DeLisi L.E., Craddock N.J., Detera-Wadleigh S., Foroud T., Gejman P., Kennedy J.L., Lendon C., Macciardi F., McKeon P., Mynett-Johnson L., Nurnberger J.I., Paterson A., Schwab S., Van Broeckhoven C., Wildenauer D., Crow T.J. Update on chromosomal locations for psychiatric disorders: report of the interim meeting of chromosome workshop chairpersons from the VIIth World Congress of Psychiatric Genetics, Monterey, California, October 14-18, 1999. Am. J. Med. Genet. 2000, 96(3):434-449.
5. Fedorenko O., Strutz-Seebohm N., Henrion U., Ureche O.N., Lang F., Seebohm G., Lang U.E. A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels. Psychopharmacology (Berl.) 2008, 199(1):47-54.
6. Hansen H.H., Ebbesen C., Mathiesen C., Weikop P., Ronn L.C., Waroux O., Scuvee-Moreau J., Seutin V., Mikkelsen J.D. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. J. Pharmacol. Exp. Ther. 2006, 318(3):1006-1019.
7. Jones L.M., Michell R.H. Breakdown of phosphatidylinositol provoked by muscarinic cholinergic stimulation of rat parotid-gland fragments. Biochem. J. 1974, 142(3):583-590.
8. Schwab S.G., Knapp M., Sklar P., Eckstein G.N., Sewekow C., Borrmann-Hassenbach M., Albus M., Becker T., Hallmayer J.F., Lerer B., Maier W., Wildenauer D.B. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIalpha gene (PIP5K2A) with schizophrenia. Mol. Psychiatry 2006, 11(9):837-846.
9. Suh B.C., Inoue T., Meyer T., Hille B. Rapid chemically induced changes of PtdIns(4, 5)P2 gate KCNQ ion channels. Science 2006, 314(5804):1454-1457.
10. Undie A.S., Friedman E. Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain. Eur. J. Pharmacol. 1992, 226(4):297-302.